Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Dupixent shows promise in treating bullous pemphigoid, with patients five times more likely to achieve remission.

flag Dupixent showed promising results in treating bullous pemphigoid, a skin condition, with five times more adults achieving sustained remission compared to those on placebo. flag The drug also significantly reduced disease severity, itch, and the need for other medications. flag This could make Dupixent the first targeted treatment for the condition, with regulatory reviews currently underway in the US and EU.

7 Articles

Further Reading